Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?

por Samara, P., Ioannou, K., Tsitsilonis, O.E.
Publicado 2016

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

por Gavalas, N G, Tsiatas, M, Tsitsilonis, O, Politi, E, Ioannou, K, Ziogas, A C, Rodolakis, A, Vlahos, G, Thomakos, N, Haidopoulos, D, Terpos, E, Antsaklis, A, Dimopoulos, M A, Bamias, A
Publicado 2012